Searched for
NOVEL ANTIBIOTIC
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...- Metals rally largely priced in, limited upside seen after strong cyclical run: Sandip SabharwalMarket expert Sandip Sabharwal advises caution, seeing stock-specific chances but limited broad market conviction. He notes Wockhardt's app...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- 5,000-year-old bacteria revived from ice can fight superbugs, but scientists see a downsideScientists have isolated a Psychrobacter SC65A.3, a bacterial strain frozen for almost 5,000 years in Romania’s Scărișoara Ice Cave. The mi...
- Wockhardt gets NDA status for novel antibiotic ZaynichWockhardt, an emerging powerhouse in the Indian pharmaceutical arena, has just scored a game-changing triumph! The US health regulator has ...
- Debt-free Orchid Pharma charts out growth planOrchid Pharma, backed by Dhanuka Group, focuses on cephalosporin antibiotics. Expansion plans include a new facility, Enmetazobactam launch...
- IIT Roorkee researchers find antibiotic against multi-drug resistant bacteriaIn a new study published in the journal, ‘Journal of Antimicrobial Chemotherapy’, IIT Roorkee researchers screened a library of 11,000 comp...
- A warm cup of green tea can help you fight 'superbugs'The natural antioxidant commonly found in green tea may help eliminate antibiotic resistant bacteria.
- Bugworks Research bags Rs 62 crore in Series AThe company plans to use the funds to deepen its clinical trials.
- Wockhardt sets up its first manufacturing facility in Middle East"With the new facility in the Middle East, we aim to focus on our commitment to developing NCEs to fight the health issues," Wockhardt Foun...
- ET Startup Awards 2017: Both Bugworks Research & Pandorum Technologies grab 'Top Innovator' awardDespite the complexities, long durations and dearth of money required for such research, several young companies are making a global impact...
- New method developed to reduce antibiotic resistanceA novel mathematical method inspired by the Darwinian evolution has been developed to reduce the development of antibiotic-resistant bacter...
- Superbugs could erase a century of medical advancesThe rise of drug-resistant superbugs could undo a century's worth of medical advancements and render surgeries deadly in the near future.
- Venus Remedies shares rally 10% on Mexico patent for PotentoxVenus Remedies shares rallied nearly 10% in morning trade, after the company received patent from Mexico for its novel antibiotic Potentox.
- Venus Remedies gets Mexico patent for PotentoxGranted by the Mexican Institute of Industrial Property, the patent protects the composition of Potentox, the company said.
- Orchid Chemicals, Allecra in pact to develop antibioticsDrug firm Orchid Chemicals & Pharmaceuticals said it has inked a strategic pact with Europe-based Allecra Therapeutics to develop novel ant...
Load More
